膦甲酸钠用于骨髓移植后巨细胞病毒性视网膜炎的治疗。
Foscarnet as treatment for cytomegalovirus retinitis following bone marrow transplantation.
作者信息
Ganly P S, Arthur C, Goldman J M, Schulenburg W E
机构信息
Department of Haematology, Hammersmith Hospital, London, UK.
出版信息
Postgrad Med J. 1988 May;64(751):389-91. doi: 10.1136/pgmj.64.751.389.
Abstract
This report describes a patient with chronic granulocytic leukaemia who developed cataracts on busulphan treatment. Following allogeneic bone marrow transplantation, he developed cytomegalovirus retinitis, which was treated successfully with trisodium phosphonoformate (foscarnet). Cytomegalovirus retinitis and its therapy, and busulphan-induced cataract are discussed.
摘要
本报告描述了一名慢性粒细胞白血病患者，其在接受白消安治疗时出现了白内障。在接受异基因骨髓移植后，他患上了巨细胞病毒性视网膜炎，使用膦甲酸钠（磷甲酸三钠）成功治愈。文中讨论了巨细胞病毒性视网膜炎及其治疗方法，以及白消安诱发的白内障。
相似文献
1
Foscarnet as treatment for cytomegalovirus retinitis following bone marrow transplantation.膦甲酸钠用于骨髓移植后巨细胞病毒性视网膜炎的治疗。
Postgrad Med J. 1988 May;64(751):389-91. doi: 10.1136/pgmj.64.751.389.
2
Treatment of cytomegalovirus retinitis with trisodium phosphonoformate hexahydrate (Foscarnet).用六水合膦甲酸钠三钠（膦甲酸钠）治疗巨细胞病毒性视网膜炎。
J Infect Dis. 1988 Mar;157(3):569-72. doi: 10.1093/infdis/157.3.569.
3
Foscarnet for cytomegalovirus retinitis.
Ann Intern Med. 1985 Dec;103(6 ( Pt 1)):962. doi: 10.7326/0003-4819-103-6-962_2.
4
Successful treatment with trisodium phosphonoformate for primary cytomegalovirus infection after heart transplantation.膦甲酸钠三钠成功治疗心脏移植术后原发性巨细胞病毒感染。
J Heart Transplant. 1987 Mar-Apr;6(2):120-2.
5
Foscarnet approved for cytomegalovirus retinitis.
Am Fam Physician. 1991 Nov;44(5):1890.
6
Clinical experiences with phosphonoformate (foscarnet) treatment of viral diseases following renal transplantation.膦甲酸钠（磷甲酸）治疗肾移植后病毒性疾病的临床经验。
Scand J Urol Nephrol Suppl. 1985;92:41-4.
7
Foscarnet for cytomegalovirus infections.膦甲酸用于巨细胞病毒感染。
Lancet. 1985 Jun 29;1(8444):1503-4. doi: 10.1016/s0140-6736(85)92272-x.
8
Treatment of cytomegalovirus pneumonitis with foscarnet (trisodium phosphonoformate) in patients with AIDS.用膦甲酸钠（三钠膦酰甲酸盐）治疗艾滋病患者的巨细胞病毒性肺炎。
J Med Virol. 1987 Jun;22(2):157-62. doi: 10.1002/jmv.1890220206.
9
Foscarnet for CMV retinitis.
Lancet. 1992 Feb 22;339(8791):501. doi: 10.1016/0140-6736(92)91119-s.
10
Simultaneous treatment of cytomegalovirus retinitis with ganciclovir and foscarnet.
Lancet. 1991 Jul 27;338(8761):250. doi: 10.1016/0140-6736(91)90385-3.
引用本文的文献
1
CMV retinitis in a stem cell transplant recipient treated with foscarnet intravitreal injection and CMV specific immunoglobulins.一名接受干细胞移植的患者，通过玻璃体内注射膦甲酸和巨细胞病毒特异性免疫球蛋白治疗巨细胞病毒性视网膜炎。
Ther Adv Hematol. 2020 Dec 10;11:2040620720975651. doi: 10.1177/2040620720975651. eCollection 2020.
2
Cytomegalovirus in hematopoietic stem cell transplant recipients.造血干细胞移植受者巨细胞病毒感染。
Hematol Oncol Clin North Am. 2011 Feb;25(1):151-69. doi: 10.1016/j.hoc.2010.11.011.
3
The human eye (retina): a site of persistent HCMV infection?人眼（视网膜）：是巨细胞病毒持续感染的部位吗？
Graefes Arch Clin Exp Ophthalmol. 2005 Jul;243(7):671-6. doi: 10.1007/s00417-004-0965-0. Epub 2005 Jan 26.
4
Foscarnet 5 versus 7 days a week treatment for severe gastrointestinal CMV disease in HIV-infected patients.每周5天与7天使用膦甲酸钠治疗HIV感染患者的严重胃肠道巨细胞病毒疾病
Infection. 1996 Mar-Apr;24(2):121-4. doi: 10.1007/BF01713315.
5
Foscarnet. A review of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with cytomegalovirus retinitis.膦甲酸钠。对其在免疫功能低下的巨细胞病毒性视网膜炎患者中的抗病毒活性、药代动力学特性及治疗应用的综述。
Drugs. 1991 Jan;41(1):104-29. doi: 10.2165/00003495-199141010-00009.
6
Pharmacokinetics of foscarnet after twice-daily administrations for treatment of cytomegalovirus disease in AIDS patients.艾滋病患者巨细胞病毒疾病治疗中，膦甲酸钠每日两次给药后的药代动力学。
Antimicrob Agents Chemother. 1992 Sep;36(9):1821-4. doi: 10.1128/AAC.36.9.1821.
本文引用的文献
1
Cytomegalovirus retinitis in immunosuppressed hosts. I. Natural history and effects of treatment with adenine arabinoside.
Ann Intern Med. 1980 Nov;93(5):655-64. doi: 10.7326/0003-4819-93-5-655.
2
Cytomegalovirus infection and specific cell-mediated immunity after marrow transplant.骨髓移植后的巨细胞病毒感染与特异性细胞介导免疫
J Infect Dis. 1980 Dec;142(6):816-24. doi: 10.1093/infdis/142.6.816.
3
Lens changes in chronic granulocytic leukemia. Possible relationship to chemotherapy.慢性粒细胞白血病中的晶状体变化。与化疗的可能关系。
Am J Ophthalmol. 1969 Sep;68(3):500-4. doi: 10.1016/0002-9394(69)90722-3.
4
Cataract after busulphan treatment.
Br Med J. 1972 Jan 22;1(5794):218-9. doi: 10.1136/bmj.1.5794.218.
5
Cataract after busulphan therapy.白消安治疗后的白内障。
Acta Haematol. 1986;76(4):236. doi: 10.1159/000206064.
6
Foscarnet for cytomegalovirus retinitis.
Ann Intern Med. 1985 Dec;103(6 ( Pt 1)):962. doi: 10.7326/0003-4819-103-6-962_2.
7
9-(1,3-Dihydroxy-2-propoxymethyl)guanine for cytomegalovirus infections in patients with the acquired immunodeficiency syndrome.
Ann Intern Med. 1985 Sep;103(3):381-2. doi: 10.7326/0003-4819-103-3-381.
8
Treatment of cytomegalovirus retinitis with 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine.用9-[2-羟基-1-(羟甲基)乙氧基甲基]鸟嘌呤治疗巨细胞病毒性视网膜炎。
Ann Intern Med. 1985 Sep;103(3):377-80. doi: 10.7326/0003-4819-103-3-377.
9
Acquired immune deficiency syndrome. Pathogenic mechanisms of ocular disease.获得性免疫缺陷综合征。眼部疾病的致病机制。
Ophthalmology. 1985 Apr;92(4):472-84. doi: 10.1016/s0161-6420(85)34008-3.
10
Treatment of CMV retinitis in an AIDS patient.
Br J Ophthalmol. 1987 Nov;71(11):810-6. doi: 10.1136/bjo.71.11.810.
Zotero 插件